The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results Bernard VrijensAntoine PironetEric Tousset Current Opinion Open access 22 December 2023 Pages: 9 - 18
“Regulatory Sandboxes” Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal Products Mathieu Guerriaud Current Opinion 09 December 2023 Pages: 19 - 23
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management Anadil JavaidCatherine BennettLavinia Spain Review Article Open access 09 January 2024 Pages: 25 - 38
A Review of the Current FDA-Approved Antibody-Drug Conjugates: Landmark Clinical Trials and Indications Meghana KesireddySrikanth Reddy KothapalliSamia Asif Review Article 29 November 2023 Pages: 39 - 54
Eliciting Exploratory Patient Preference Data: A Case Study in a Rare Disease Kerrie-Anne HoAnna PierceCarol Mansfield Original Research Article Open access 21 December 2023 Pages: 55 - 62
Evaluation of Physician Knowledge of Safety and Safe Use Information for Intravitreal Aflibercept Injection in Europe: A Second Survey of Physicians Following Dissemination of Updated Risk-Minimization Materials Laurie J. ZografosElizabeth AndrewsKiliana Suzart-Woischnik Original Research Article Open access 05 December 2023 Pages: 63 - 73